Didier has 30 years’ experience in drug delivery using colloids, ranging from basic research to clinical trials. He has collaborated with BioChem Pharma, GSK, Sanofi Pasteur and Chiron-Novartis on the evaluation of nasal vaccine using nanotechnologies. As an international expert in nanomedicine, he presided at the French Society for Controlled Release, was a board member of the French Society of Nanomedicine, and has over 110 international publications and 23 patents.
After a PhD on drug targeting in collaboration with the World Health Organization, Didier developed a patented technology for vaccine applications based on polysaccharidic nanoparticles with a phospholipid bi-layer.
His experience, innovative research and patented technology are at the heart of Vaxinano.
